Inactive Instrument

Analyst Reco. Briacell Therapeutics Corp Toronto S.E.

Equities

BriaCell Has Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients	12-28	MT
BriaCell Brief: Has Reported 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients; Comes After Shares Jumped 18% on Wednesday	12-28	MT
BriaCell Therapeutics Corp. Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients	12-28	CI
HC Wainwright Adjusts BriaCell Therapeutics' Price Target to $20 From $24.85, Keeps Buy Rating	23-10-03	MT
HC Wainwright Initiates BriaCell Therapeutics at Buy With $25 Price Target	22-02-14	MT

No results for this search